Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics of NPC-01 and IKH-01
NCT01253824Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Jan 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
01
Overview
Phase 3 trial of norethindrone and ethinyl estradiol in unintended pregnancy (2 arms), sponsored by Nobelpharma Co., Ltd. Primary endpoints: Area Under the Curve of Estradiol at Day 24 and Area Under the Curve of Progesterone at Day 24. Started Jan 2011; status: completed.
02
Drugs
norethindroneethinyl estradiol
03
Conditions
unintended pregnancy
Beyond the preview
Go deeper on NCT01253824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01253824.